Explore

Trendline Trendline
Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer

Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer

Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer
Trendline Trendline
Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer
Trendline Trendline
Moderna's mRNA-4359 and Merck's Keytruda Show Promising Results in Melanoma Treatment

Moderna's mRNA-4359 and Merck's Keytruda Show Promising Results in Melanoma Treatment

Moderna's mRNA-4359 and Merck's Keytruda Show Promising Results in Melanoma Treatment
Trendline Trendline
Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership

Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership

Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership
Trendline Trendline
CatalYm Appoints Christian S. Schade as Chairman Amid Clinical Advancements

CatalYm Appoints Christian S. Schade as Chairman Amid Clinical Advancements

CatalYm Appoints Christian S. Schade as Chairman Amid Clinical Advancements
Trendline Trendline
FDA Approves Taiho Oncology's ADC ARC-02 for Phase 1 Clinical Trials in Non-Hodgkin Lymphoma

FDA Approves Taiho Oncology's ADC ARC-02 for Phase 1 Clinical Trials in Non-Hodgkin Lymphoma

FDA Approves Taiho Oncology's ADC ARC-02 for Phase 1 Clinical Trials in Non-Hodgkin Lymphoma
Trendline Trendline
Encoded Therapeutics to Present ETX101 Data at ASGCT Symposium, Highlighting Advances in Dravet Syndrome Treatment

Encoded Therapeutics to Present ETX101 Data at ASGCT Symposium, Highlighting Advances in Dravet Syndrome Treatment

Encoded Therapeutics to Present ETX101 Data at ASGCT Symposium, Highlighting Advances in Dravet Syndrome Treatment
Trendline Trendline
Sapient Introduces Tumor Protein Mapping Platform to Enhance Cancer Treatment Insights

Sapient Introduces Tumor Protein Mapping Platform to Enhance Cancer Treatment Insights

Sapient Introduces Tumor Protein Mapping Platform to Enhance Cancer Treatment Insights
Trendline Trendline
AbbVie Reports Strong Q1 Earnings, Raises 2026 Outlook Amid Strategic Portfolio Adjustments

AbbVie Reports Strong Q1 Earnings, Raises 2026 Outlook Amid Strategic Portfolio Adjustments

AbbVie Reports Strong Q1 Earnings, Raises 2026 Outlook Amid Strategic Portfolio Adjustments
Trendline Trendline
Emergent BioSolutions Secures $50M Deal with SAB Biotherapeutics for Diabetes Treatment

Emergent BioSolutions Secures $50M Deal with SAB Biotherapeutics for Diabetes Treatment

Emergent BioSolutions Secures $50M Deal with SAB Biotherapeutics for Diabetes Treatment
Trendline Trendline
Affinia Therapeutics Presents AFTX-201 Gene Therapy for BAG3-Associated Cardiomyopathy at ASGCT Meeting

Affinia Therapeutics Presents AFTX-201 Gene Therapy for BAG3-Associated Cardiomyopathy at ASGCT Meeting

Affinia Therapeutics Presents AFTX-201 Gene Therapy for BAG3-Associated Cardiomyopathy at ASGCT Meeting
Trendline Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call